Generic drug maker Barr Pharmaceuticals Inc. Tuesday said it launched a patent challenge against GlaxoSmithKline PLC over its prostate drug Avodart. ...
The Montvale, New Jersey based Barr filed its ANDA containing a paragraph IV certification for a generic Avodart with the US Food & Drug Administration in ...
... Barr Laboratories had indeed begun a challenge of the patents listed by GlaxoSmithKline in connection with its Avodart, 0.5mg soft gelatin capsules. ...
Avodart had annual sales of approximately $362 million in the US, based on IMS sales data for the 12-month period ending December 2007. ...
Barr filed its ANDA containing a paragraph IV certification for a generic Avodart product with the FDA in October 2007, and received notification of the ...
The Montvale, New Jersey based Barr filed its ANDA containing a paragraph IV certification for a generic Avodart with the US Food & Drug Administration in ...
Generic drug maker Barr Pharmaceuticals Inc. Tuesday said it launched a patent challenge against GlaxoSmithKline PLC over its prostate drug Avodart. ...
all 8 news articles
all 4 news articles
The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Avodart. ...